Moskau, Russia

Amiran Sh Revishvili


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2000-2002

Loading Chart...
2 patents (USPTO):Explore Patents

Title: **Amiran Sh Revishvili: Innovator in Cardiac Technology**

Introduction:

Amiran Sh Revishvili, located in Moscow, Russia, is a recognized inventor with significant contributions to the field of cardiac technology. With a total of two patents to his name, Revishvili has dedicated his career to developing innovative solutions aimed at improving heart health.

Latest Patents:

Revishvili's most recent patents include a **Multiphase Defibrillator with Conductive Housing** and a **Device for Determining Tachycardiac Heart Rhythm Disturbances**. The multiphase defibrillator features an implantable housing and an electrode set that includes both right-ventricular and coronary sinus electrodes, providing a novel approach to cardiac defibrillation. The device for determining tachycardiac heart rhythm disturbances is equipped with a stimulation pulse generator, multiple sensor electrodes, and an evaluation device, enabling it to detect, evaluate, and classify heart rhythm anomalies efficiently.

Career Highlights:

Throughout his career, Amiran Sh Revishvili has worked with notable companies such as Biotronik Mess- und Therapiegeräte GmbH & Co. and Ingenieurbüro Berlin. His work with these organizations has allowed him to refine his skills and focus on cutting-edge technologies related to cardiac care.

Collaborations:

His collaboration with Tran Thong has been instrumental in advancing the design and functionality of his inventions. Working together, they have explored innovative methods to enhance heart rhythm management technologies, contributing to the overall improvement of patient outcomes.

Conclusion:

Amiran Sh Revishvili's work in the domain of cardiac technology highlights his commitment to innovation and improving healthcare solutions. His patents not only demonstrate his expertise but also pave the way for future developments in cardiac care, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…